US 12370206
Therapy for inhibition of single-stranded RNA virus replication
granted A61KA61K31/435A61K31/438
Quick answer
US patent 12370206 (Therapy for inhibition of single-stranded RNA virus replication) held by RedHill Biopharma Ltd. expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RedHill Biopharma Ltd.
- Grant date
- Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/435, A61K31/438, A61K31/4409, A61K31/7048